These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34326009)

  • 1. Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug.
    Ameen F; Mamidala E; Davella R; Vallala S
    J Infect Public Health; 2021 Oct; 14(10):1454-1460. PubMed ID: 34326009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing immune boosting and anti-viral efficacy of
    Dinata R; Nisa N; Arati C; Rasmita B; Uditraj C; Siddhartha R; Bhanushree B; Saeed-Ahmed L; Manikandan B; Bidanchi RM; Abinash G; Pori B; Khushboo M; Roy VK; Gurusubramanian G
    J Biomol Struct Dyn; 2024; 42(1):43-81. PubMed ID: 37021347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19.
    Arumugam S; Vadivel K; Dhaked DK; Prasanna VS; Yellurkar ML; Das P; Manoharan R; Thomas AJ; Singh L; Singh S; Velayutham R
    Homeopathy; 2024 Feb; 113(1):16-24. PubMed ID: 37673083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2.
    Majrashi TA; El Hassab MA; Mahmoud SH; Mostafa A; Wahsh EA; Elkaeed EB; Hassan FE; Eldehna WM; Abdelgawad SM
    PLoS One; 2024; 19(4):e0301086. PubMed ID: 38662719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.
    Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK
    J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach.
    Indu P; Rameshkumar MR; Arunagirinathan N; Al-Dhabi NA; Valan Arasu M; Ignacimuthu S
    J Infect Public Health; 2020 Dec; 13(12):1856-1861. PubMed ID: 33168456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
    Nguyen HL; Thai NQ; Truong DT; Li MS
    J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
    Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
    J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
    Chowdhury T; Roymahapatra G; Mandal SM
    Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection.
    Arman M; Alam S; Maruf RA; Shams Z; Islam MN
    Narra J; 2024 Apr; 4(1):e319. PubMed ID: 38798846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches.
    Zhang C; Liu J; Sui Y; Liu S; Yang M
    Sci Rep; 2023 Dec; 13(1):21404. PubMed ID: 38049492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and Therapeutic Potential Zinc Metallodrugs Drug Discovery: Identification of SARS-CoV-2 Replication and Spike/ACE2 Inhibitors.
    Ngoepe MP; Tapala KC; Clayton HS
    Curr Comput Aided Drug Des; 2022; 18(7):519-534. PubMed ID: 36154578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach.
    Kushwaha PP; Singh AK; Bansal T; Yadav A; Prajapati KS; Shuaib M; Kumar S
    Front Cell Infect Microbiol; 2021; 11():730288. PubMed ID: 34458164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies.
    Arumugam GS; Sen A; Dash SS; Mitra K; Doble M; Rajaraman G; Gummadi SN
    J Biomol Struct Dyn; 2022; 40(22):12358-12379. PubMed ID: 34533107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the dual effects of antiviral drugs on SARS-CoV-2 receptors and the ACE2 receptor using structure-based virtual screening and molecular dynamics simulation.
    Jahantigh HR; Ahmadi N; Shahbazi B; Lovreglio P; Habibi M; Stufano A; Gouklani H; Ahmadi K
    J Biomol Struct Dyn; 2023; 41(13):6051-6073. PubMed ID: 35876061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
    Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
    Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
    Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.